# Cost- Effectiveness and Quality of Life Assessment in Bipolar Disorder Depressive Episode

> **NCT02918097** · PHASE4 · COMPLETED · sponsor: **Federal University of Rio Grande do Sul** · enrollment: 78 (actual)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** Lithium Carbonate
- **DRUG:** Sertraline
- **DRUG:** Nortriptyline
- **DRUG:** Risperidone

## Key facts

- **NCT ID:** NCT02918097
- **Lead sponsor:** Federal University of Rio Grande do Sul
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2014-11
- **Final completion:** 2015-09
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2020-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02918097

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02918097, "Cost- Effectiveness and Quality of Life Assessment in Bipolar Disorder Depressive Episode". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02918097. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*